DJIA 17,067.56 -30.89 -0.18%
NASDAQ 4,598.19 17.92 0.39%
S&P 500 2,002.28 -1.09 -0.05%
market minute promo

BioMarin Pharmaceutical (NASDAQ: BMRN)

70.39 -0.83 (-1.17%)

REAL-TIME: Last trade at

Extended Hours: $70.40 $0.01 (0.01%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

BMRN $70.39 -1.17%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $71.45
Previous Close $71.22
Daily Range $69.18 - $71.45
52-Week Range $55.04 - $84.25
Market Cap $10.4B
P/E Ratio -53.95
Dividend (Yield) $0.00 (0.0%)
Volume 792,051
Average Daily Volume 1,092,114
Current FY EPS -$1.30

Sector

Healthcare

Industry

Drugs

BioMarin Pharmaceutical (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary Rss Feed

7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know

Highlights from Regeneron's conference call.

NVO, BMRN And ILMN, 3 Health Care Stocks Pushing The Sector Lower

Can BioMarin Pharmaceutical (BMRN) Run Higher on Strong Earnings Estimate Revisions? - Tale of the T

Can BioMarin Pharmaceutical (BMRN) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog

Why BioMarin Pharmaceutical (BMRN) Could Beat Earnings Estimates Again - Tale of the Tape

Why BioMarin Pharmaceutical (BMRN) Could Beat Earnings Estimates Again - Tale of the Tape

BioMarin Weathers The Storm

Insider Trading Alert - BMRN, RFMD And KOS Traded By Insiders

3 Stocks Moving The Health Care Sector Upward

BioMarin Q2 Loss Narrower than Expected, Revenue Guidance Up - Analyst Blog

BioMarin Pharmaceutical's (BMRN) CEO Jean-Jacques Bienaimé on Q2 2014 Results - Earnings Call Transc

BioMarin Pharmaceutical's (BMRN) CEO Jean-Jacques Bienaimé on Q2 2014 Results - Earnings Call Transcript

See More BMRN News...

BMRN's Top Competitors

BMRN $70.39 (-1.17%)
Current stock: BMRN
AMGN $137.96 (-1.02%)
Current stock: AMGN
GILD $109.36 (1.67%)
Current stock: GILD
BIIB $342.68 (-0.10%)
Current stock: BIIB